住院2型糖尿病患者的骨密度变化及其与代谢指标的相关性分析
本文关键词:住院2型糖尿病患者的骨密度变化及其与代谢指标的相关性分析 出处:《南昌大学》2016年硕士论文 论文类型:学位论文
【摘要】:目的:研究住院2型糖尿病(T2DM)患者的骨密度(BMD)变化及合并骨质疏松的相关因素,为糖尿病性骨质疏松(DOP)的早期诊断与防治提供依据。方法:将入选的733例住院2型糖尿病患者按照平均骨密度值分为骨量正常组(A组)、骨量减低组(B组)和骨质疏松组(C组),对比三组患者的性别、年龄、体重指数(BMI)、病程、空腹血糖(FPG)、餐后1h血糖(1h PG)、餐后2h血糖(2h PG)、空腹胰岛素(FINS)、餐后1h胰岛素(1h INS)、餐后2h胰岛素(2h INS)、胰岛素抵抗指数(Homa-IR)、胰岛素敏感指数(ISI)、糖化血红蛋白(Hb A1c)、尿微量白蛋白定量、血脂、尿酸、甲状旁腺素(PTH)、血钙(Ca)、血磷(P)和骨碱性磷酸酶(BALP)等指标之间的差异,并进行相关性分析。结果:1、住院T2DM患者中骨量减少的检出率为49.7%,骨质疏松(OP)的检出率为12.4%,其中女性患者OP的检出率大于男性,有明显统计学差异(P0.05)。2、在一般临床资料的对比中,C组的年龄和病程均明显大于A、B两组(P0.05),且B组的年龄明显大于A组(P0.05),但是病程在A、B两组间则无明显差异(P0.05);而A、B组的BMI均明显大于C组(P0.05),A组的BMI明显大于B组。3、在血糖及胰岛素水平的比较中,C组的FPG、2h PG均明显大于A、B两组(P0.05),且B组的2h PG明显大于A组(P0.05),但是FPG在A、B两组间无统计学差异(P0.05);A组的Homa-IR明显小于B、C两组(P0.05),A组的ISI明显大于B、C两组(P0.05),但Homa-IR、ISI在B、C两组间均无统计学差异(P0.05);而1h PG、FINS、1h INS、2h INS、Hb A1c在三组中均无统计学差异(P0.05)。4、在代谢指标的对比中,C组的HDL-C水平明显高于A、B两组(P0.05);A、B组的尿酸水平明显高于C组(P0.05),且A组的尿酸明显高于B组(P0.05);而尿微量白蛋白、TC、TG、LDL-C在三组间无明显差异(P0.05)。5、在骨代谢指标及BMD值的对比中,A、B组的腰椎L1-L4及双侧股骨颈的BMD值均明显大于C组(P0.05),且A组各部位的BMD值均大于B组(P0.05);A、B组的BALP、PTH均明显小于C组(P0.05),且A组的BALP明显小于B组(P0.05),但PTH在A、B组间无统计学差异(P0.05);而血钙、磷在三组间无明显差异(P0.05)。6、T2DM患者的BMI、FINS、ISI、尿酸与各部位BMD值呈正相关(P0.05),年龄、FPG、2h PG、Homa-IR、HDL-C与各部位BMD值呈负相关(P0.05)。7、进一步进行多元逐步回归分析后,年龄(β=-0.041,P=0.000)、BMI(β=0.063,P=0.005)、FPG(β=-0.236,P=0.000)、HDL-C(β=-0.649,P=0.005)、尿酸(β=0.002,P=0.047)仍与骨密度独立相关。结论:1、住院的50岁以上2型糖尿病患者中骨量减少及OP的发生率占60%以上,其中绝经后女性较男性更易患OP。2、高龄、低体重、糖尿病病程长、空腹血糖控制不佳、胰岛功能差、胰岛素抵抗、高高密度脂蛋白胆固醇、低尿酸均是2型糖尿病合并骨质疏松的高危因素。
[Abstract]:Objective: to study the changes of bone mineral density (BMD) and the related factors of osteoporosis in patients with type 2 diabetes mellitus (T2DM). Methods: 733 inpatients with type 2 diabetes mellitus were divided into two groups according to the average bone mineral density (BMD). Sex, age, body mass index (BMI), course of disease, fasting blood glucose (FPG), postprandial blood glucose (1 h) and postprandial blood glucose (1 h) were compared between group B (group B) and group C (group C). 2 h postprandial blood glucose, 2 h PGN, fasting insulin, 1 h insulin, 1 h insulin, 2 h postprandial insulin, 2 h ins). Insulin resistance index (ISI), insulin sensitivity index (ISI), glycosylated hemoglobin (HbA1cN), urinary albumin, serum lipids and uric acid. The differences of PTH, Ca, P) and BALP (bone alkaline phosphatase) were analyzed. Results: 1. The detectable rate of osteopenia and osteoporosis OPO in T2DM patients was 49.7 and 12.4respectively. The detection rate of op in female patients was higher than that in men. The age and course of disease in group C were significantly larger than those in group A and B (P 0.05). The age of group B was significantly larger than that of group A (P 0.05), but there was no significant difference in the course of disease between group A and group B (P 0.05). The BMI of group A was significantly higher than that of group C (P 0.05). The BMI of group A was significantly larger than that of group B (0.3), and the level of blood glucose and insulin in group C was significantly higher than that of group C (FPG). 2 h PG was significantly higher than that of Agna B group (P 0 05), and 2 h PG in B group was significantly higher than that in A group (P 0 05), but FPG was higher in A group than that in A group (P 0 05). There was no statistical difference between group B and group B (P 0.05). The Homa-IR of group A was significantly lower than that of group A (P 0.05), but the ISI of group A was significantly higher than that of group B (P 0.05), but Homa-IRI was higher than that of group B (P 0.05). There was no statistical difference between group C and group C (P 0.05). However, there was no significant difference in HbA1c between the three groups in 1h PGN FINSN 1h and 1h INS1c, and there was no significant difference among the three groups (P0.05A1c) in the comparison of metabolic indexes. The level of HDL-C in group C was significantly higher than that in group A and B (P 0.05). The level of uric acid in group A was significantly higher than that in group C (P 0.05), and the level of uric acid in group A was significantly higher than that in group B (P 0.05). However, there was no significant difference in LDL-C between the three groups in urine microalbuminuria (TCX) and TGG. 5. There was no significant difference between the three groups (P < 0. 05), and there was no significant difference between the three groups in bone metabolism index and BMD value. The BMD values of L1-L4 and bilateral femoral neck in group B were significantly higher than those in group C (P 0.05), and the BMD values in group A were higher than those in group B (P 0.05). The BALP of group A was significantly lower than that of group B (P 0.05), but that of group A was lower than that of group B (P 0.05), but the PTH of group A was lower than that of group A. There was no statistical difference between group B and group B (P 0.05). However, there was no significant difference in serum calcium and phosphorus among the three groups. There was a positive correlation between uric acid and BMD value in all parts of BMI-FINSISI. There was a negative correlation between HDL-C and BMD value in two hours of PGHA-IRL. Further multivariate stepwise regression analysis was carried out. Age (尾 -0.041) and BMI0.000 (尾 -0.063 / P0. 005 / FPG (尾 -0.236 / P0. 000)). HDL-C (尾 -0.649) and uric acid (尾 -0.002) were still independent of BMD. Conclusion: 1. The incidence of osteopenia and op accounted for more than 60% in the hospitalized patients over 50 years old with type 2 diabetes mellitus. Postmenopausal women were more likely to develop OP.2than men, the elderly, low body weight and long course of diabetes. Poor control of fasting blood glucose, poor islet function, insulin resistance, high density lipoprotein cholesterol and low uric acid were all high risk factors for type 2 diabetes mellitus with osteoporosis.
【学位授予单位】:南昌大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R587.1;R580
【相似文献】
相关期刊论文 前10条
1 张杰;张庆华;邬小微;梁晓萍;李体远;马乐群;;吸烟、酗酒对深圳地区成年人骨密度的影响[J];现代预防医学;2008年02期
2 陈佩丽;张芳蓉;徐刚;;血锌和血铅对婴幼儿骨密度的影响[J];实用临床医学;2008年09期
3 彭利晖;胡灯明;王三斌;;儿童急性淋巴细胞性白血病治疗后骨密度的变化[J];临床军医杂志;2010年05期
4 张大鼎;;运动与中小学生骨密度的研究[J];体育世界(学术版);2010年11期
5 石天山;刘喜军;朱争华;李云峰;;部队2010年入伍战士骨密度相关影响因素调查[J];河北联合大学学报(医学版);2012年02期
6 石天山;刘喜军;朱争华;李云峰;;某部2009年新兵骨密度现状调查及干预观察[J];实用骨科杂志;2012年05期
7 李彩霞;;7863例婴幼儿骨密度结果分析[J];中国优生与遗传杂志;2013年01期
8 马彩霞;张珊珊;胡丽;孙颖慧;;中老年骨密度调查分析及健康宣教[J];中国疗养医学;2013年04期
9 敖梅;运动对绝经后妇女骨密度的影响[J];国外医学(物理医学与康复学分册);1999年03期
10 刘喜军;石天山;贾元杰;王彩辉;;某部新兵骨密度变化状况调查与分析[J];中国骨质疏松杂志;2013年12期
相关会议论文 前10条
1 秦潇;冷松;王镇山;;慢性阻塞性肺疾病患者骨密度改变及相关因素分析[A];中华医学会呼吸病学年会——2011(第十二次全国呼吸病学学术会议)论文汇编[C];2011年
2 何玉香;李瑾;何代璇;徐红;隆路娟;;运动对青少年骨密度的影响[A];骨质疏松研究与防治第二卷——第四届全国骨质疏松学术研讨会论文集[C];1996年
3 刘燕;于长隆;张美荣;;运动对青年人骨密度影响的初步观察[A];第八届全国骨质疏松年会暨第五届全国钙剂年会会议文集[C];2002年
4 雷晨;;宁夏回族人群定量CT骨密度研究[A];中华医学会第五次中青年骨质疏松和骨矿盐疾病学术会议论文集[C];2013年
5 熊炎昊;杜宁;陈伟珍;刘涛;唐旭生;;绝经后妇女的骨密度与身高关系的回顾性研究[A];中华医学会第三次全国骨质疏松和骨矿盐疾病学术会议暨骨质疏松诊断技术继续教育学习班论文汇编[C];2004年
6 盛正妍;游利;陈瑾瑜;张黎铭;;绝经后妇女血叶酸水平与骨密度相关性的研究[A];中华医学会第四次全国骨质疏松和骨矿盐疾病学术会议论文汇编[C];2006年
7 宋淑军;刘春荣;苗劲蔚;刘霞;;绝经对妇女骨密度的影响[A];骨质疏松研究与防治第二卷——第四届全国骨质疏松学术研讨会论文集[C];1996年
8 盛正妍;游利;陈瑾瑜;张黎铭;;绝经后妇女血叶酸水平与骨密度相关性的研究[A];中华医学会第四次全国骨质疏松和骨矿盐疾病学术会议论文汇编[C];2006年
9 郭梁;邹亮畴;;运动对绝经后女性骨密度影响的追踪调查研究[A];第十三届全国运动生物力学学术交流大会论文汇编[C];2009年
10 关菁;戴兆亨;沈浣;田莉;高伯山;;中国北方绝经后汉族妇女雌激素受体基因多态性与骨密度关系的相关性研究[A];全国老年骨质疏松专题学术研讨会论文汇编[C];2000年
相关重要报纸文章 前4条
1 记者 张洁 通讯员 胡晓云;二成儿童和三成老人骨密度低于正常值[N];湖北日报;2005年
2 中国科学院上海生命科学院研究员 林旭;年轻时骨健康惠及一生[N];健康报;2007年
3 高小扁;骨密度,最熟悉的陌生概念[N];21世纪药店;2014年
4 张杰 王宏宇 杨志敏 非国家食品药品监管局药品审评中心;以骨密度为终点指标 密切关注不良反应[N];中国医药报;2011年
相关博士学位论文 前6条
1 刘文亚;新疆汉维哈三个民族人群骨密度定量CT测量及其影响因素的相关研究[D];新疆医科大学;2002年
2 李学军;素食膳食对动脉粥样硬化危险因素及骨密度的影响[D];重庆医科大学;2010年
3 程钱璇子;北京市东城区汉族绝经后妇女维生素D营养状况及其影响因素的调查[D];北京协和医学院;2009年
4 傅晓华;女性骨质健康的流行病学研究[D];浙江大学;2012年
5 陈瑛;绝经影响骨量和激素疗法抑制骨丢失的前瞻性研究[D];中国协和医科大学;2007年
6 矫杰;一、北京地区汉族妇女瘦素受体基因Gln223Arg多态性和PPARγ基因C161→T多态性与骨密度关系的研究 二、甲状旁腺激素片段1-34对去卵巢大鼠骨质疏松症治疗作用的研究[D];中国协和医科大学;2004年
相关硕士学位论文 前10条
1 熊昕;昆明市1~3岁幼儿骨密度影响因素分析[D];昆明医学院;2009年
2 许贤姬;延边和冲绳县小学生生活方式与骨密度关系的比较研究[D];延边大学;2008年
3 翟永川;能谱CT成像对成人腰椎骨密度测定研究[D];兰州大学;2015年
4 张余玲;2型糖尿病合并非酒精性脂肪肝与骨密度的关系[D];安徽医科大学;2015年
5 戴雨o,
本文编号:1408517
本文链接:https://www.wllwen.com/yixuelunwen/nfm/1408517.html